The data demonstrated that MALT1 PROTACs induce MALT1 degradation in the human diffuse large B-cell lymphoma cell line OCI-Ly3, suggesting that MALT1 PROTACs may be excellent drugs for the treatment of ABC-DLBCL and other lymphomas [128]. This evidence concerns the gene MALT1 and lymphoma.